Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 14 May 24 424B5 Prospectus supplement for primary offering
- 14 Feb 24 424B5 Prospectus supplement for primary offering
- 13 Feb 24 424B5 Prospectus supplement for primary offering
-
13 Feb 24 S-3ASR Automatic shelf registration
IMNM similar filings
Filing view
External links
Exhibit 23.3
Consent of Independent Auditors
We consent to the incorporation by reference in this Registration Statement of Immunome, Inc. on Form S-3 of our report dated August 8, 2023, relating to the financial statements of Morphimmune, Inc. as of and for the years ended December 31, 2022 and 2021, appearing in the Current Report on Form 8-K/A of Immunome, Inc. dated September 29, 2023, filed with the Securities and Exchange Commission. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ Moss Adams LLP
Seattle, Washington
February 13, 2024